MANAGEMENT OF STAGE T1 SUPERFICIAL BLADDER CANCER WITH BCG IMMUNOTHERAPY

Bcg Immunotherapy ◽

Stage T1

756: Neutrophil Granulocytes are Essential During BCG Immunotherapy of Superficial Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)34925-5 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 205-205

Author(s):

Henrik Suttmann ◽

Josef Riemensberger ◽

Andreas Böhle ◽

Dieter Jocham ◽

Sven Brandau

Keyword(s):

Bladder Cancer ◽

Neutrophil Granulocytes ◽

A Stochastic Optimal Control Model for BCG Immunotherapy in Superficial Bladder Cancer

Mathematical Modelling of Natural Phenomena ◽

10.1051/mmnp/201712507 ◽

2017 ◽

Vol 12 (5) ◽

pp. 99-119 ◽

Cited By ~ 1

Author(s):

R. Aboulaich ◽

A. Darouichi ◽

I. Elmouki ◽

A. Jraifi

Keyword(s):

Optimal Control ◽

Bladder Cancer ◽

Stochastic Optimal Control ◽

Control Model ◽

318 ANTI-ANGIOGENIC EFFECTS OF THE SUPERANTIGEN STAPHYLOCOCCAL ENTEROTOXIN B (SEB) AND BACILLUS CALMETTE-GUERIN (BCG) IMMUNOTHERAPY IN THE SUPERFICIAL BLADDER CANCER (SBC)

The Journal of Urology ◽

10.1016/j.juro.2010.02.382 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Leonardo O. Reis ◽

Valéria H.A. Cagnon ◽

Ubirajara Ferreira ◽

Athanase Billis ◽

Wagner J. Fávaro

Keyword(s):

Bladder Cancer ◽

Staphylococcal Enterotoxin ◽

Staphylococcal Enterotoxin B ◽

Bacillus Calmette Guerin ◽

Bcg Immunotherapy ◽

Enterotoxin B

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-009-0557-9 ◽

2009 ◽

Vol 135 (9) ◽

pp. 1169-1175 ◽

Cited By ~ 9

Author(s):

Ioannis Zachos ◽

Panagiotis A. Konstantinopoulos ◽

Gerasimos P. Vandoros ◽

Michalis V. Karamouzis ◽

Athanasios G. Papatsoris ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Reverse Transcriptase ◽

Predictive Value ◽

Telomerase Reverse Transcriptase ◽

Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(17)37241-5 ◽

1992 ◽

Vol 147 (2) ◽

pp. 376-379 ◽

Cited By ~ 57

Author(s):

Gregg R. Eure ◽

Maria R. Cundiff ◽

Paul F. Schellhammer

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Bacillus Calmette Guerin ◽

Stage T1

BCG immunotherapy for superficial bladder cancer

Journal of the Royal Society of Medicine ◽

10.1177/014107680109400305 ◽

2001 ◽

Vol 94 (3) ◽

pp. 119-123 ◽

Cited By ~ 26

Author(s):

C Richard W Lockyer ◽

David A Gillatt

Keyword(s):

Bladder Cancer ◽

A Discrete Isoperimetric Optimal Control Approach for BCG Immunotherapy in Superficial Bladder Cancer: Discussions on Results of Different Optimal Doses

International Journal of Applied and Computational Mathematics ◽

10.1007/s40819-017-0337-1 ◽

2017 ◽

Vol 3 (S1) ◽

pp. 1-18 ◽

Cited By ~ 2

Author(s):

Meryem Alkama ◽

Mostafa Rachik ◽

Ilias Elmouki

Keyword(s):

Optimal Control ◽

Bladder Cancer ◽

Control Approach ◽

Bcg Immunotherapy ◽

Optimal Control Approach

Stability and persistence analysis of mathematical model of BCG immunotherapy in superficial bladder cancer

Applied Mathematical Sciences ◽

10.12988/ams.2017.77237 ◽

2017 ◽

Vol 11 ◽

pp. 2291-2304

Author(s):

Ida Ayu Putu Ari Utari ◽

Hariyanto

Keyword(s):

Mathematical Model ◽

Bladder Cancer ◽

320Neutrophil granulocytes play an essential role during BCG immunotherapy of superficial bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(05)80328-8 ◽

2005 ◽

Vol 4 (3) ◽

pp. 82

Author(s):

H. Suttmann ◽

J. Riemensberger ◽

A. Böhle ◽

T. Goldmann ◽

D. Jocham ◽

...

Keyword(s):

Bladder Cancer ◽

Essential Role ◽

496 RELEVANCE OF URINARY INTERFERON-GAMMA IN THE PROGNOSIS OF SUPERFICIAL BLADDER CANCER TREATED WITH BCG IMMUNOTHERAPY

European Urology Supplements ◽

10.1016/s1569-9056(07)60494-1 ◽

2007 ◽

Vol 6 (2) ◽

pp. 146

Author(s):

I. Zoumpos ◽

S. Touloupidis ◽

A. Giakoumelos ◽

T. Galaktidou ◽

A. Kortsaris ◽

...

Keyword(s):

Bladder Cancer ◽

Interferon Gamma ◽